Does the Use of Dianatal Reduce the Rate of Episiotomy and Vaginal Tears in Birth?
Launched by MEIR MEDICAL CENTER · Jul 2, 2015
Trial Information
Current as of June 12, 2025
Unknown status
Keywords
ClinConnect Summary
The risk for vaginal tears during birth is about 20%. These tears require surgical repair, are painful and make the recovery of the mother more difficult. Less commonly there is a risk of tear infection and regional scarring that make intercourse more difficult. Moreover, according to some studies, it appears that there is a link between damage to the pelvic floor and vagina during labor and Urinary incontinence in stress later in life.
It is clear that there is an advantage for the prevention of vaginal tears. Dianatal is a gel preparation, designed for use in births, in order to reduce t...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women on their first Childbirth
- • Singleton pregnancy
- • Over 37 weeks of pregnancy
- • In active labor
- • Women who intend to have a vaginally birth
- • Women aged 18-45
- Exclusion Criteria:
- • Multiple pregnancy
- • Births before 37 weeks
- • History of tear degree III or more
- • Women who intended to give birth by Caesarean section
About Meir Medical Center
Meir Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor of clinical studies, Meir Medical Center is committed to fostering collaboration among healthcare professionals, researchers, and patients to explore new therapies and treatment modalities. With a focus on ethical practices and patient safety, the center aims to contribute significantly to the scientific community while enhancing the quality of care provided to its diverse patient population. Through its robust infrastructure and multidisciplinary approach, Meir Medical Center stands at the forefront of medical innovation, driving progress in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials